{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:02:03Z","timestamp":1763535723988,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010098","name":"Shanghai Association for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013279","name":"National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cmi.2020.07.033","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T11:55:43Z","timestamp":1596023743000},"page":"775-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety and immunogenicity of an alum-adjuvanted whole-virion H7N9 influenza vaccine: a randomized, blinded, clinical trial"],"prefix":"10.1016","volume":"27","author":[{"given":"Shilei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuelian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengli","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.07.033_bib1","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2020.07.033_bib2","first-page":"137","article-title":"Avian influenza virus transmission to mammals","volume":"385","author":"Herfst","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.cmi.2020.07.033_bib3","first-page":"71","article-title":"Human infections with recently emerging highly pathogenic H7N9 avian influenza virus in China","volume":"75","author":"Zhang","year":"2017","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2020.07.033_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jama.2015.7916","article-title":"Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial","volume":"314","author":"Jackson","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2020.07.033_bib5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jama.2014.12854","article-title":"Serological responses to an avian influenza A\/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"Mulligan","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2020.07.033_bib6","doi-asserted-by":"crossref","first-page":"234ra55","DOI":"10.1126\/scitranslmed.3008761","article-title":"A\u00a0cell culture-derived MF59-adjuvanted pandemic A\/H7N9 vaccine is immunogenic in adults","volume":"6","author":"Bart","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cmi.2020.07.033_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1503\/cmaj.060204","article-title":"Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada","volume":"176","author":"Skowronski","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.cmi.2020.07.033_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jviromet.2005.10.001","article-title":"Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test","volume":"132","author":"Meijer","year":"2006","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.cmi.2020.07.033_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(05)64783-6","article-title":"Avian influenza virus isolated from a woman with conjunctivitis","volume":"348","author":"Kurtz","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.07.033_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/infdis\/jit430","article-title":"Avian-origin influenza A (H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study","volume":"209","author":"Yang","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2020.07.033_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.cmi.2020.07.033_bib12","first-page":"63","article-title":"Haemagglutination-inhibiting antibody to influenza virus","volume":"115","author":"de Jong","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.cmi.2020.07.033_bib13","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/infdis\/jiw414","article-title":"Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults","volume":"214","author":"Madan","year":"2016","journal-title":"J\u00a0Infect Dis"},{"author":"WHO","key":"10.1016\/j.cmi.2020.07.033_bib15"},{"key":"10.1016\/j.cmi.2020.07.033_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/21645515.2018.1515454","article-title":"Comparative effectiveness of H7N9 vaccines in healthy individuals","volume":"15","author":"Zheng","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2020.07.033_bib17","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1056\/NEJMoa073121","article-title":"A\u00a0clinical trial of a whole-virus H5N1 vaccine derived from cell culture","volume":"358","author":"Ehrlich","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2020.07.033_bib18","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1128\/JVI.03520-12","article-title":"Replication and immunogenicity of swine, equine, and avian H3 subtype influenza viruses in mice and ferrets","volume":"87","author":"Baz","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2020.07.033_bib19","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1016\/S0264-410X(03)00234-2","article-title":"Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice","volume":"21","author":"Takada","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2020.07.033_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-3083.2005.01633.x","article-title":"Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB\/c mice","volume":"62","author":"Hovden","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cmi.2020.07.033_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2249.1998.00714.x","article-title":"Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation","volume":"114","author":"Saurwein-Teissl","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cmi.2020.07.033_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000138","article-title":"Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling","volume":"4","author":"Geeraedts","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2020.07.033_bib23","doi-asserted-by":"crossref","first-page":"25ra4","DOI":"10.1126\/scitranslmed.3000759","article-title":"Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes","volume":"2","author":"Koyama","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cmi.2020.07.033_bib24","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0264-410X(00)00394-7","article-title":"Detoxification of endotoxin by aluminum hydroxide adjuvant","volume":"19","author":"Shi","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2020.07.033_bib25","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ajhg.2015.09.008","article-title":"Amino acid variation in HLA Class II proteins is a major determinant of humoral response to common viruses","volume":"97","author":"Hammer","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cmi.2020.07.033_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13073-018-0568-8","article-title":"Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines","volume":"10","author":"Scepanovic","year":"2018","journal-title":"Genome Med"},{"key":"10.1016\/j.cmi.2020.07.033_bib27","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.vaccine.2017.06.044","article-title":"Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: a phase I\/II, prospective, randomized, open-label trial","volume":"35","author":"Wu","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2020.07.033_bib28","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.4049\/jimmunol.0900398","article-title":"Original antigenic sin responses to influenza viruses","volume":"183","author":"Kim","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2020.07.033_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002802","article-title":"Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China","volume":"8","author":"Lessler","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2020.07.033_bib30","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.20130212","article-title":"Immune history shapes specificity of pandemic H1N1 influenza antibody responses","volume":"210","author":"Li","year":"2013","journal-title":"J\u00a0Exp Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20304419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20304419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:27:31Z","timestamp":1761118051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X20304419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1198743X20304419"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.07.033","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of an alum-adjuvanted whole-virion H7N9 influenza vaccine: a randomized, blinded, clinical trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}